3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Unknown
1
Suspended
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
12
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
5
Triple Negative Breast Neoplasms
4
Stomach Neoplasms
4
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Fallopian Tube Neoplasms
3
Advanced Pancreatic Cancer
3
Esophageal Neoplasms
2
Biliary Tract Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Staging IV NSCLC
1
Squamous Cell Carcinoma of Lung
1
Solid Tumor
1
Sertoli-Leydig Cell Tumor
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Cancer Non-resectable
1
Pancreatic Adenocarcinoma
1
Ovarian gynandroblastoma
1
Obesity
1
Neurotoxicity Syndromes
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Liver Neoplasms
1
HER2-negative Breast Cancer
1
HER2+ Breast Cancer
1
Interventions
Oxaliplatin
4
Gemcitabine
4
Fluorouracil
3
Capecitabine
3
Tegafur
2
Stents
2
Radiofrequency Ablation
2
Leucovorin
2
Irinotecan
2
toripalimab
1
tislelizumab
1
taxane
1
surufatinib
1
lenvatinib
1
apixaban
1
apatinib
1
aldesleukin
1
Urination
1
Trastuzumab
1
Tomography, X-Ray Computed
1
Temozolomide
1
Taxes
1
Standard of Care
1
Sorafenib
1
S 1 (combination)
1
Rivaroxaban
1
Radiotherapy
1
Polymerase Chain Reaction
1
Platinum Compounds
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Gallbladder Neoplasms
×
Taxes
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled